Dr. Mark J. Gloth, D.O., has been named chief medical officer for Gilchrist. He will provide medical leadership for our geriatric, palliative, hospice and medical director services in homes, residential care facilities, inpatient centers, offices and hospitals throughout the Baltimore region. Gloth brings more than 25 years of leadership experience as a physician executive. He most recently .
Researchers from Kessler Foundation and Kessler Institute for Rehabilitation (collectively "Kessler") are enrolling participants in a national trial of a breakthrough device for improving recovery after stroke. Kessler locations in West Orange and Saddle Brook, NJ, are among the 20 sites across the U.S. participating in the EMAGINE Stroke Recovery Trial, which pairs therapeutic exercise with stimulation of the brain through an investigational wearable device.
Alabama NewsCenter — $2 2 million grant extends UAB traumatic brain injury model system for five years : The Alabama Weather Blog alabamawx.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alabamawx.com Daily Mail and Mail on Sunday newspapers.
Avidity Biosciences Inc (RNA) Announces Phase 1/2 EXPLORE44™ Trial of AOC 1044 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.